Cartilage Regeneration Market

The Global Cartilage Regeneration Market was worth USD 421.5 million in 2016 and is
projected to be growing at a CAGR of 14.2%, to touch USD 818.71 million by 2021. The main
function of cartilage is to connect bones together. It does so by its elasticity to bend a bit
but at the same time resisting stretching. It is found in many parts of the body such as joints,
the rib cage, nose, ear and throat and in between the back-bones.
The amplest type of cartilage found in the human body is the hyaline cartilage, which is
found as a form of supportive tissue in the ears, nose and the throat (trachea, smaller
respiratory tubes and larynx). Cartilage tissue is vital because of the flexibility and stability of
movement it provides.
The growth of the Global Cartilage Regeneration Market is driven by factors such as
increasing incidence of joint and bone disorders such as Osteoarthritis, which are a result of
damage or wear and tear of connective tissues and the growing aging population with
related connective tissue ailments. Furthermore, increase in the obese population and rising
frequency of sports injuries & road accidents are set to boost market growth in the future.
However, unfavourable reimbursement policies and the high cost of therapy are the major
restraints of market growth.
The Global Cartilage Regeneration Market is segmented on the basis of the Type of
Treatment, Application and Geography. Based on the Type of Treatment used, the Cartilage
Regeneration market is divided into Cell Based Approaches and Non-Cell Based Approaches.
The Cell based Approaches are further divided into Chondrocyte Transplantation, Stem Cells
and Growth Factor Technology. Non-cell based approach is further classified into Tissue
Scaffolds and Cell-free composites. Based on Application, the Cartilage Regeneration Market
is segmented into Hyaline Cartilage Regeneration and Fibrocartilage Regeneration.
The market has been geographically segmented into North America, Europe, Asia-Pacific,
Latin America and Middle-East & Africa. As of 2016, North America leads the market,
accounting for the major global market share and expanding with the highest CAGR. North
America’s lead is warranted by the presence of high number of registered patients and
increasing use of cartilage repair or regeneration to treat sports injuries and other accidents.
Europe comes in second in terms of market share owing to the rising awareness about
blood related disorders and the swift availability of treatment in terms of plasma
fractionation. However, Asia-Pacific is expected to catch up fast during the forecast period
majorly because of the presence of huge population base, once the costs of cartilage
regeneration come down with growth in R&D and technology.
The Global Market for Cartilage Regeneration is broadly categorized based on type,
Services, End User and Region.
1. Based on type of treatment
Introduction
Cell Based Approaches
o Stem Cells